iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF) Trading Down 1.3% – Should You Sell?

iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDFGet Free Report)’s share price dropped 1.3% during mid-day trading on Thursday . The company traded as low as $35.94 and last traded at $35.94. Approximately 27,417 shares changed hands during mid-day trading, an increase of 254% from the average daily volume of 7,748 shares. The stock had previously closed at $36.43.

iShares LifePath Target Date 2050 ETF Stock Up 1.0%

The business’s 50-day moving average price is $36.90 and its 200 day moving average price is $35.10. The company has a market capitalization of $41.39 million, a P/E ratio of 20.56 and a beta of 0.85.

Institutional Inflows and Outflows

An institutional investor recently raised its position in iShares LifePath Target Date 2050 ETF stock. Citadel Advisors LLC grew its position in shares of iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDFFree Report) by 78.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,107 shares of the company’s stock after purchasing an additional 6,208 shares during the period. Citadel Advisors LLC owned approximately 1.24% of iShares LifePath Target Date 2050 ETF worth $518,000 at the end of the most recent quarter.

About iShares LifePath Target Date 2050 ETF

(Get Free Report)

The iShares LifePath Target Date 2050 ETF USD (ITDF) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.

Further Reading

Receive News & Ratings for iShares LifePath Target Date 2050 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2050 ETF and related companies with MarketBeat.com's FREE daily email newsletter.